Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colleoni

Showing results (51-60 of 264) with videos related to

Pageof 27
Sort By:
Breast (Edinburgh, Scotland)|February 27, 2009
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancerZhuoxin Sun, Aron Goldhirsch, Karen N Price, et al.
Anticancer Research|January 18, 2003
Intrathecal chemotherapy in carcinomatous meningitis from breast cancerLaura Orlando, Giuseppe Curigliano, Marco Colleoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93, Marco Colleoni, Shari Gelber, et al.
BMC Cancer|September 19, 2006
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancerLaura Orlando, Anna Cardillo, Raffaella Ghisini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2010
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancerMarco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Breast Cancer Research and Treatment|July 17, 2008
Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution seriesGiuseppe Viale, Nicole Rotmensz, Patrick Maisonneuve, et al.
Cancer|December 13, 2005
Video-assisted management of malignant pleural effusion in breast carcinomaRoberto Gasparri, Francesco Leo, Giulia Veronesi, et al.
Breast (Edinburgh, Scotland)|October 22, 2011
Positive axillary sentinel lymph node: is axillary dissection always necessary?Viviana Galimberti, Camelia Chifu, Suanly Rodriguez Perez, et al.
Targeted Oncology|October 18, 2019
Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to TrastuzumabHans-Christian Kolberg, Marco Colleoni, Patricia Santi, et al.
Clinical Breast Cancer|December 15, 2010
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancerRosalba Torrisi, Anna Cardillo, Giuseppe Cancello, et al.
Pageof 27

Showing results (51-60 of 264) with videos related to

Sort By:
Pageof 27
Breast (Edinburgh, Scotland)|February 27, 2009
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancerZhuoxin Sun, Aron Goldhirsch, Karen N Price, et al.
Anticancer Research|January 18, 2003
Intrathecal chemotherapy in carcinomatous meningitis from breast cancerLaura Orlando, Giuseppe Curigliano, Marco Colleoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93, Marco Colleoni, Shari Gelber, et al.
BMC Cancer|September 19, 2006
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancerLaura Orlando, Anna Cardillo, Raffaella Ghisini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2010
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancerMarco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Breast Cancer Research and Treatment|July 17, 2008
Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution seriesGiuseppe Viale, Nicole Rotmensz, Patrick Maisonneuve, et al.
Cancer|December 13, 2005
Video-assisted management of malignant pleural effusion in breast carcinomaRoberto Gasparri, Francesco Leo, Giulia Veronesi, et al.
Breast (Edinburgh, Scotland)|October 22, 2011
Positive axillary sentinel lymph node: is axillary dissection always necessary?Viviana Galimberti, Camelia Chifu, Suanly Rodriguez Perez, et al.
Targeted Oncology|October 18, 2019
Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to TrastuzumabHans-Christian Kolberg, Marco Colleoni, Patricia Santi, et al.
Clinical Breast Cancer|December 15, 2010
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancerRosalba Torrisi, Anna Cardillo, Giuseppe Cancello, et al.
Pageof 27